Geniposide Ameliorates Liver Fibrosis Through Reducing Oxidative Stress and Inflammatory Respose, Inhibiting Apoptosis and Modulating Overall Metabolism

Liver fibrosis is a progressive liver damage condition caused by various factors and may progress toward liver cirrhosis, and even hepatocellular carcinoma. Many studies have found that the disfunction in metabolism could contribute to the development of liver fibrosis. Geniposide, derived from Gard...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lu Yang, Liping Bi, Lulu Jin, Yuming Wang, Yuting Li, Zixuan Li, Wenju He, Huantian Cui, Jing Miao, Li Wang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/007b33173beb4bc6bfeeebb8fa255313
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:007b33173beb4bc6bfeeebb8fa255313
record_format dspace
spelling oai:doaj.org-article:007b33173beb4bc6bfeeebb8fa2553132021-11-30T16:38:19ZGeniposide Ameliorates Liver Fibrosis Through Reducing Oxidative Stress and Inflammatory Respose, Inhibiting Apoptosis and Modulating Overall Metabolism1663-981210.3389/fphar.2021.772635https://doaj.org/article/007b33173beb4bc6bfeeebb8fa2553132021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.772635/fullhttps://doaj.org/toc/1663-9812Liver fibrosis is a progressive liver damage condition caused by various factors and may progress toward liver cirrhosis, and even hepatocellular carcinoma. Many studies have found that the disfunction in metabolism could contribute to the development of liver fibrosis. Geniposide, derived from Gardenia jasminoides J. Ellis, has been demonstrated with therapeutic effects on liver fibrosis. However, the exact molecular mechanisms of such liver-protection remain largely unknown. The aim of this study was to explored the effect of geniposide on metabolic regulations in liver fibrosis. We used carbon tetrachloride (CCl4) to construct a mouse model of liver fibrosis and subsequently administered geniposide treatment. Therapeutic effects of geniposide on liver fibrosis were accessed through measuring the levels of hepatic enzymes in serum and the pathological changes in liver. We also investigated the effects of geniposide on inflammatory response, oxidative stress and apoptosis in liver. Furthermore, serum untargeted metabolomics were used to explore the metabolic regulatory mechanisms behind geniposide on liver fibrosis. Our results demonstrated that geniposide could reduce the levels of hepatic enzymes in serum and ameliorate the pathological changes in liver fibrosis mice. Geniposide enhanced the activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) and decreased methane dicarboxylic aldehyde (MDA) levels in liver. Geniposide treatment also decreased the levels of interleukin (IL)-6, IL-1β, and tumor necrosis factor-alpha (TNF-a) in liver tissue homogenate. Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay (TUNEL) staining demonstrated that geniposide could reduce the apoptosis of hepatocytes. Geniposide increased the protein expression of B-cell lymphoma-2 (Bcl-2) and downregulated the protein expression of Bcl-2 Associated X (Bax), cleaved-Caspase 3, and cleaved-Caspase 9. Serum untargeted metabolomics analysis demonstrated that geniposide treatment improved the metabolic disorders including glycerophospholipid metabolism, arginine and proline metabolism, and arachidonic acid (AA) metabolism. In conclusion, our study demonstrated the protective effects of geniposide on liver fibrosis. We found that geniposide could treat liver fibrosis by inhibiting oxidative stress, reducing inflammatory response and apoptosis in the liver, and modulating glycerophospholipid, and arginine, proline, and AA metabolism processes.Lu YangLu YangLiping BiLulu JinYuming WangYuting LiYuting LiZixuan LiWenju HeHuantian CuiJing MiaoLi WangFrontiers Media S.A.articleliver fibrosisgeniposideuntargeted metabolomic analysisoxidative stressinflammationapoptosisTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic liver fibrosis
geniposide
untargeted metabolomic analysis
oxidative stress
inflammation
apoptosis
Therapeutics. Pharmacology
RM1-950
spellingShingle liver fibrosis
geniposide
untargeted metabolomic analysis
oxidative stress
inflammation
apoptosis
Therapeutics. Pharmacology
RM1-950
Lu Yang
Lu Yang
Liping Bi
Lulu Jin
Yuming Wang
Yuting Li
Yuting Li
Zixuan Li
Wenju He
Huantian Cui
Jing Miao
Li Wang
Geniposide Ameliorates Liver Fibrosis Through Reducing Oxidative Stress and Inflammatory Respose, Inhibiting Apoptosis and Modulating Overall Metabolism
description Liver fibrosis is a progressive liver damage condition caused by various factors and may progress toward liver cirrhosis, and even hepatocellular carcinoma. Many studies have found that the disfunction in metabolism could contribute to the development of liver fibrosis. Geniposide, derived from Gardenia jasminoides J. Ellis, has been demonstrated with therapeutic effects on liver fibrosis. However, the exact molecular mechanisms of such liver-protection remain largely unknown. The aim of this study was to explored the effect of geniposide on metabolic regulations in liver fibrosis. We used carbon tetrachloride (CCl4) to construct a mouse model of liver fibrosis and subsequently administered geniposide treatment. Therapeutic effects of geniposide on liver fibrosis were accessed through measuring the levels of hepatic enzymes in serum and the pathological changes in liver. We also investigated the effects of geniposide on inflammatory response, oxidative stress and apoptosis in liver. Furthermore, serum untargeted metabolomics were used to explore the metabolic regulatory mechanisms behind geniposide on liver fibrosis. Our results demonstrated that geniposide could reduce the levels of hepatic enzymes in serum and ameliorate the pathological changes in liver fibrosis mice. Geniposide enhanced the activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) and decreased methane dicarboxylic aldehyde (MDA) levels in liver. Geniposide treatment also decreased the levels of interleukin (IL)-6, IL-1β, and tumor necrosis factor-alpha (TNF-a) in liver tissue homogenate. Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling assay (TUNEL) staining demonstrated that geniposide could reduce the apoptosis of hepatocytes. Geniposide increased the protein expression of B-cell lymphoma-2 (Bcl-2) and downregulated the protein expression of Bcl-2 Associated X (Bax), cleaved-Caspase 3, and cleaved-Caspase 9. Serum untargeted metabolomics analysis demonstrated that geniposide treatment improved the metabolic disorders including glycerophospholipid metabolism, arginine and proline metabolism, and arachidonic acid (AA) metabolism. In conclusion, our study demonstrated the protective effects of geniposide on liver fibrosis. We found that geniposide could treat liver fibrosis by inhibiting oxidative stress, reducing inflammatory response and apoptosis in the liver, and modulating glycerophospholipid, and arginine, proline, and AA metabolism processes.
format article
author Lu Yang
Lu Yang
Liping Bi
Lulu Jin
Yuming Wang
Yuting Li
Yuting Li
Zixuan Li
Wenju He
Huantian Cui
Jing Miao
Li Wang
author_facet Lu Yang
Lu Yang
Liping Bi
Lulu Jin
Yuming Wang
Yuting Li
Yuting Li
Zixuan Li
Wenju He
Huantian Cui
Jing Miao
Li Wang
author_sort Lu Yang
title Geniposide Ameliorates Liver Fibrosis Through Reducing Oxidative Stress and Inflammatory Respose, Inhibiting Apoptosis and Modulating Overall Metabolism
title_short Geniposide Ameliorates Liver Fibrosis Through Reducing Oxidative Stress and Inflammatory Respose, Inhibiting Apoptosis and Modulating Overall Metabolism
title_full Geniposide Ameliorates Liver Fibrosis Through Reducing Oxidative Stress and Inflammatory Respose, Inhibiting Apoptosis and Modulating Overall Metabolism
title_fullStr Geniposide Ameliorates Liver Fibrosis Through Reducing Oxidative Stress and Inflammatory Respose, Inhibiting Apoptosis and Modulating Overall Metabolism
title_full_unstemmed Geniposide Ameliorates Liver Fibrosis Through Reducing Oxidative Stress and Inflammatory Respose, Inhibiting Apoptosis and Modulating Overall Metabolism
title_sort geniposide ameliorates liver fibrosis through reducing oxidative stress and inflammatory respose, inhibiting apoptosis and modulating overall metabolism
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/007b33173beb4bc6bfeeebb8fa255313
work_keys_str_mv AT luyang geniposideamelioratesliverfibrosisthroughreducingoxidativestressandinflammatoryresposeinhibitingapoptosisandmodulatingoverallmetabolism
AT luyang geniposideamelioratesliverfibrosisthroughreducingoxidativestressandinflammatoryresposeinhibitingapoptosisandmodulatingoverallmetabolism
AT lipingbi geniposideamelioratesliverfibrosisthroughreducingoxidativestressandinflammatoryresposeinhibitingapoptosisandmodulatingoverallmetabolism
AT lulujin geniposideamelioratesliverfibrosisthroughreducingoxidativestressandinflammatoryresposeinhibitingapoptosisandmodulatingoverallmetabolism
AT yumingwang geniposideamelioratesliverfibrosisthroughreducingoxidativestressandinflammatoryresposeinhibitingapoptosisandmodulatingoverallmetabolism
AT yutingli geniposideamelioratesliverfibrosisthroughreducingoxidativestressandinflammatoryresposeinhibitingapoptosisandmodulatingoverallmetabolism
AT yutingli geniposideamelioratesliverfibrosisthroughreducingoxidativestressandinflammatoryresposeinhibitingapoptosisandmodulatingoverallmetabolism
AT zixuanli geniposideamelioratesliverfibrosisthroughreducingoxidativestressandinflammatoryresposeinhibitingapoptosisandmodulatingoverallmetabolism
AT wenjuhe geniposideamelioratesliverfibrosisthroughreducingoxidativestressandinflammatoryresposeinhibitingapoptosisandmodulatingoverallmetabolism
AT huantiancui geniposideamelioratesliverfibrosisthroughreducingoxidativestressandinflammatoryresposeinhibitingapoptosisandmodulatingoverallmetabolism
AT jingmiao geniposideamelioratesliverfibrosisthroughreducingoxidativestressandinflammatoryresposeinhibitingapoptosisandmodulatingoverallmetabolism
AT liwang geniposideamelioratesliverfibrosisthroughreducingoxidativestressandinflammatoryresposeinhibitingapoptosisandmodulatingoverallmetabolism
_version_ 1718406422298886144